Press Resease

Preclinical CRO Treatment Market - Global Industry Analysis

Preclinical CRO Treatment Market - by Type (Pharmacokinetics/Pharmacodynamics (PK/PD), Early Phase Development Services, Toxicology Testing, Laboratory Services, Clinic Research Services, Stability Testing, Physical Characterization, Raw Material Testing, Batch Release Testing, And Analytical Testing And Other Consulting Services), by Therapeutic Area (CNS Disorders, Oncology, Cardiovascular Diseases, Infectious Diseases, Respiratory Disorders, Immunological Disorders, Diabetes, Others), by End-User (Medical Device Companies, Pharmaceutical And Biopharmaceutical Companies, And Academic Institutes), and by Region: Global Industry Perspective, Comprehensive Analysis and Forecast 2019 – 2026

Published Date: 25-Aug-2020 Category: Medical Device Report Format : PDF Pages: 110 Report Code: ZMR-2887 Status : Published

Global Preclinical CRO Treatment Market was valued at USD 4,200 Million in 2019 and is expected to reach over USD 7,542.9 Million by 2026, growing at a CAGR of around 9.2% during the forecast period from 2020 to 2026

Description

According to the report, the global preclinical CRO treatment market was valued at USD 4,200 Million in 2019 and is expected to reach over USD 7,542.9 Million by 2026, growing at a CAGR of around 9.2% during the forecast period from 2020 to 2026.

A preclinical CRO allows new developers of medical products (including electronics, medicines, biologics and more) to show that they are safe and effective in live models. Rising in the spending on CRO services can propel the market growth, and also increase in the pressure to meet the R&D expenses is likely to boost the market in forecast period.

Global Preclinical CRO Treatment Market: Overview

A preclinical CRO treatment is likely to offer the knowledge, experience, and skill needed to take a pharmaceutical medical device or product from the drawing board to distribution. The preclinical contract research organizations (CRO) sector has witnessed a period of tremendous development in the past, profiting from quickly growing (R&D) spending. Several pharmaceutical companies have lost revenue owing to growing patent expirations thus encouraging several manufacturers to outsource factors of the drug manufacturing method to CROs to decrease costs. Due to this, CROs are witnessing significant development.

Global Preclinical CRO Treatment Market: Growth Factors

The market is expected to witness profitable growth in the coming future due to increase in R&D spending in the early stage of advancement along with the rise in a number of medicines in the preclinical stage. Hence, growth in outsourcing penetration is likely to contribute to the increasing demand and popularity of several life science companies particularly for outsourced preclinical (CRO) treatment. Expansion in the number of rare/complex drugs which are entering into preclinical CRO treatment and increasing pressure to meet R&D expenses are projected to contribute to the increasing requirement for quality CROs, thus contributing to the preclinical CRO treatment market expansion.

Global Preclinical CRO Treatment Market: Segmentation

The global preclinical CRO treatment market has been divided into the following division and sub-divisions. The global preclinical CRO treatment market is classified in terms of type, which is further divided into pharmacokinetics/pharmacodynamics (PK/PD), early phase development services, toxicology testing, laboratory services, clinic research services, stability testing, physical characterization, raw material testing, batch release testing, and analytical testing and other consulting services. The global preclinical CRO treatment market is fragmented in terms of the therapeutic area which includes CNS disorders, oncology, cardiovascular diseases, infectious diseases, respiratory disorders, immunological disorders, diabetes as well as other therapeutic areas. The global preclinical CRO treatment market is segmented in terms of end-user into medical device companies, pharmaceutical and biopharmaceutical companies, and academic institutes.

Global Preclinical CRO Treatment Market: Regional Analysis

North America is expected to hold the largest market share in the global preclinical CRO market. It is anticipated to dominate and lead the global preclinical CRO treatment market in the coming future. The occurrence of established premature stage advancement CROs, for instance, LabCorp and Charles River Laboratories for improved quality of work, economic stability, established acumen & scientific experience, and logistic benefits to big life science companies are likely to be the few aspects which are expected to contribute to the domination of the region.

The varying industry model of rising cost of R&D and MNC’s outsourcing are projected to propel the global preclinical CRO treatment market in the Asia Pacific due to the cost-effectiveness of preclinical CROs treatment in countries such as China and India. Asia Pacific is anticipated to experience rapid development in the global preclinical CRO treatment market in the coming years.

Global Preclinical CRO Treatment Market: Competitive Players

Some of the most important market players in the global preclinical CRO treatment market are Paraxel International Corporation, Laboratory Corporation of America, Charles River Laboratories International, Inc., Eurofins Scientific, Envigo, Wuxi AppTec, PRA Health Science, Inc., Pharmaceutical Product Development, LLC., and Medpace, Inc., among others.

Global Preclinical CRO Treatment Market: Regional Segment Analysis

  • North America
    • The U.S.
  • Europe
    • The UK
    • France
    • Germany
  • The Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • The Middle East and Africa

What Reports Provides

  • Full in-depth analysis of the parent market
  • Important changes in market dynamics
  • Segmentation details of the market
  • Former, on-going, and projected market analysis in terms of volume and value
  • Assessment of niche industry developments
  • Market share analysis
  • Key strategies of major players
  • Emerging segments and regional markets
  • Testimonials to companies in order to fortify their foothold in the market.

Table Of Content

  • Chapter 1 Preface
    • 1.1 Report Description
    • 1.1 Report Scope
  • Chapter 2 Research Methodology
    • 2.1 Research Methodology
    • 2.2 Secondary Research
    • 2.3 Primary Research
    • 2.4 Models
      • 2.4.1 Company Share Analysis Model
      • 2.4.2 Revenue Based Modelling
    • 2.5 Research Limitations
  • Chapter 3 Executive Summary
    • 3.1 Global Preclinical CRO Treatment Market, 2016 – 2026 (USD Million)
    • 3.2 Global Preclinical CRO Treatment Market: Snapshot
  • Chapter 4 Preclinical CRO Treatment Market – Industry Analysis
    • 4.1 Introduction
    • 4.2 Market Drivers
      • 4.2.1 Driving Factor 1 Analysis
      • 4.2.2 Driving Factor 2 Analysis:
    • 4.3 Market Restraints
      • 4.3.1 Restraining Factor Analysis
    • 4.4 Market Opportunities
      • 4.4.1 Market Opportunity & Use-case Analysis
      • 4.4.2 Use – Cases for Preclinical CRO Treatment
    • 4.5 Porter’s Five Forces Analysis
    • 4.6 COVID 19 Impact Analysis
      • 4.6.1.1 Impact on Product Development and Technology Adoption
      • 4.6.1.2 Gap Analysis
  • Chapter 5 Investment Proposition Analysis
    • 5.1 Global Preclinical CRO Treatment Market Attractiveness, By Type
    • 5.2 Global Preclinical CRO Treatment Market Attractiveness, By Therapeutic Area
    • 5.3 Global Preclinical CRO Treatment Market Attractiveness, By End-User
    • 5.4 Global Preclinical CRO Treatment Market Attractiveness, By Region
  • Chapter 6 Competitive Landscape
    • 6.1 Company Market Share Analysis - 2019
      • 6.1.1 Global Preclinical CRO Treatment Market: Company Market Share, 2019
    • 6.2 Strategic Developments
    • 7.1 Global Preclinical CRO Treatment Market Overview: By Type
      • 7.1.1 Global Preclinical CRO Treatment Market Revenue Share, By Type, 2019 & 2026
    • 7.2 Global Preclinical CRO Treatment Market Analysis/Overview – By Type
      • 7.2.1 Pharmacokinetics/Pharmacodynamics – Overview/Analysis
      • 7.2.2 Early Phase Development Services – Overview/Analysis
      • 7.2.3 Toxiculogy Testing – Overview/Analysis
      • 7.2.4 Laboratory Services – Overview/Analysis
      • 7.2.5 Clinic Research Services – Overview/Analysis
      • 7.2.6 Stability Testing – Overview/Analysis
      • 7.2.7 Physical Characterization – Overview/Analysis
      • 7.2.8 Raw Material Testing – Overview/Analysis
      • 7.2.9 Batch Release Testing – Overview/Analysis
      • 7.2.10 Other Services – Overview/Analysis
    • 7.3 Pharmacokinetics/Pharmacodynamics
      • 7.3.1 Global Preclinical CRO Treatment Market for Pharmacokinetics/Pharmacodynamics, Revenue (USD Million) 2016 - 2026
    • 7.4 Early Phase Development Services
      • 7.4.1 Global Preclinical CRO Treatment Market for Early Phase Development Services, Revenue (USD Million) 2016 - 2026
    • 7.5 Toxiculogy Testing
      • 7.5.1 Global Preclinical CRO Treatment Market for Toxiculogy Testing, Revenue (USD Million) 2016 - 2026
    • 7.6 Laboratory Services
      • 7.6.1 Global Preclinical CRO Treatment Market for Laboratory Services, Revenue (USD Million) 2016 - 2026
    • 7.7 Clinic Research Services
      • 7.7.1 Global Preclinical CRO Treatment Market for Clinic Research Services, Revenue (USD Million) 2016 - 2026
    • 7.8 Stability Testing
      • 7.8.1 Global Preclinical CRO Treatment Market for Stability Testing, Revenue (USD Million) 2016 - 2026
    • 7.9 Physical Characterization
      • 7.9.1 Global Preclinical CRO Treatment Market for Physical Characterization, Revenue (USD Million) 2016 - 2026
    • 7.10 Raw Material Testing
      • 7.10.1 Global Preclinical CRO Treatment Market for Raw Material Testing, Revenue (USD Million) 2016 - 2026
    • 7.11 Batch Release Testing
      • 7.11.1 Global Preclinical CRO Treatment Market for Batch Release Testing, Revenue (USD Million) 2016 - 2026
    • 7.12 Other Services
      • 7.12.1 Global Preclinical CRO Treatment Market for Other Services, Revenue (USD Million) 2016 - 2026
    • 8.1 Global Preclinical CRO Treatment Market Overview: By Therapeutic Area
      • 8.1.1 Global Preclinical CRO Treatment Market Revenue Share, By Therapeutic Area, 2019 & 2026
    • 8.2 Global Preclinical CRO Treatment Market Analysis/Overview – By Therapeutic Area
      • 8.2.1 CNS Disorders – Overview/Analysis
      • 8.2.2 Onculogy – Overview/Analysis
      • 8.2.3 Cardiovascular Diseases – Overview/Analysis
      • 8.2.4 Infectious Diseases – Overview/Analysis
      • 8.2.5 Respiratory Diseases – Overview/Analysis
      • 8.2.6 Immunulogical Diseases – Overview/Analysis
      • 8.2.7 Diabetes – Overview/Analysis
      • 8.2.8 Others – Overview/Analysis
    • 8.3 CNS Disorders
      • 8.3.1 Global Preclinical CRO Treatment Market for CNS Disorders, Revenue (USD Million) 2016 - 2026
    • 8.4 Onculogy
      • 8.4.1 Global Preclinical CRO Treatment Market for Onculogy, Revenue (USD Million) 2016 - 2026
    • 8.5 Cardiovascular Diseases
      • 8.5.1 Global Preclinical CRO Treatment Market for Cardiovascular Diseases, Revenue (USD Million) 2016 - 2026
    • 8.6 Infectious Diseases
      • 8.6.1 Global Preclinical CRO Treatment Market for Infectious Diseases, Revenue (USD Million) 2016 - 2026
    • 8.7 Respiratory Diseases
      • 8.7.1 Global Preclinical CRO Treatment Market for Respiratory Diseases, Revenue (USD Million) 2016 - 2026
    • 8.8 Immunulogical Diseases
      • 8.8.1 Global Preclinical CRO Treatment Market for Immunulogical Diseases, Revenue (USD Million) 2016 - 2026
    • 8.9 Diabetes
      • 8.9.1 Global Preclinical CRO Treatment Market for Diabetes, Revenue (USD Million) 2016 - 2026
    • 8.10 Others
      • 8.10.1 Global Preclinical CRO Treatment Market for Others, Revenue (USD Million) 2016 - 2026
    • 9.1 Global Preclinical CRO Treatment Market Overview: By End-User
      • 9.1.1 Global Preclinical CRO Treatment Market Revenue Share, By End-User, 2019 & 2026
    • 9.2 Global Preclinical CRO Treatment Market Analysis/Overview – By End-User
      • 9.2.1 Medical Device Companies – Overview/Analysis
      • 9.2.2 Pharmaceutical & Biopharmaceutical Companies – Overview/Analysis
      • 9.2.3 Academic Institutes – Overview/Analysis
    • 9.3 Medical Device Companies
      • 9.3.1 Global Preclinical CRO Treatment Market for Medical Device Companies, Revenue (USD Million) 2016 - 2026
    • 9.4 Pharmaceutical & Biopharmaceutical Companies
      • 9.4.1 Global Preclinical CRO Treatment Market for Pharmaceutical & Biopharmaceutical Companies, Revenue (USD Million) 2016 - 2026
    • 9.5 Academic Institutes
      • 9.5.1 Global Preclinical CRO Treatment Market for Academic Institutes, Revenue (USD Million) 2016 - 2026
  • Chapter 10 Preclinical CRO Treatment Market – Regional Analysis
    • 10.1 Global Preclinical CRO Treatment Market: Regional Overview
      • 10.1.1 Global Preclinical CRO Treatment Market Revenue Share, by Region, 2019 & 2026
      • 10.1.2 Global Preclinical CRO Treatment Market Revenue, by Region, 2016 – 2026 (USD Million)
    • 10.2 North America
      • 10.2.1 North America Preclinical CRO Treatment Market Revenue, 2016 - 2026 (USD Million)
      • 10.2.2 North America Preclinical CRO Treatment Market Revenue, by Country, 2016 – 2026 (USD Million)
      • 10.2.3 North America Preclinical CRO Treatment Market Revenue, By Type, 2016 – 2026
      • 10.2.4 North America Preclinical CRO Treatment Market Revenue, By Therapeutic Area, 2016 – 2026
      • 10.2.5 North America Preclinical CRO Treatment Market Revenue, By End-User, 2016 – 2026
      • 10.2.6 U.S.
      • 10.2.7 Canada
    • 10.3 Europe
      • 10.3.1 Europe Preclinical CRO Treatment Market Revenue, 2016 - 2026 (USD Million)
      • 10.3.2 Europe Preclinical CRO Treatment Market Revenue, by Country, 2016 – 2026 (USD Million)
      • 10.3.3 Europe Preclinical CRO Treatment Market Revenue, By Type, 2016 – 2026
      • 10.3.4 Europe Preclinical CRO Treatment Market Revenue, By Therapeutic Area, 2016 – 2026
      • 10.3.5 Europe Preclinical CRO Treatment Market Revenue, By End-User, 2016 – 2026
      • 10.3.6 Germany
      • 10.3.7 France
      • 10.3.8 U.K.
      • 10.3.9 Rest of Europe
    • 10.4 Asia Pacific
      • 10.4.1 Asia Pacific Preclinical CRO Treatment Market Revenue, 2016 - 2026 (USD Million)
      • 10.4.2 Asia Pacific Preclinical CRO Treatment Market Revenue, by Country, 2016 – 2026 (USD Million)
      • 10.4.3 Asia Pacific Preclinical CRO Treatment Market Revenue, By Type, 2016 – 2026
      • 10.4.4 Asia Pacific Preclinical CRO Treatment Market Revenue, By Therapeutic Area, 2016 – 2026
      • 10.4.5 Asia Pacific Preclinical CRO Treatment Market Revenue, By End-User, 2016 – 2026
      • 10.4.6 China
      • 10.4.7 Japan
      • 10.4.8 India
      • 10.4.9 Rest of Asia Pacific
    • 10.5 Latin America
      • 10.5.1 Latin America Preclinical CRO Treatment Market Revenue, 2016 - 2026 (USD Million)
      • 10.5.2 Latin America Preclinical CRO Treatment Market Revenue, by Country, 2016 – 2026 (USD Million)
      • 10.5.3 Latin America Preclinical CRO Treatment Market Revenue, By Type, 2016 – 2026
      • 10.5.4 Latin America Preclinical CRO Treatment Market Revenue, By Therapeutic Area, 2016 – 2026
      • 10.5.5 Latin America Preclinical CRO Treatment Market Revenue, By End-User, 2016 – 2026
      • 10.5.6 Brazil
      • 10.5.7 Rest of Latin America
    • 10.6 The Middle-East and Africa
      • 10.6.1 The Middle-East and Africa Preclinical CRO Treatment Market Revenue, 2016 - 2026 (USD Million)
      • 10.6.2 The Middle-East and Africa Preclinical CRO Treatment Market Revenue, by Country, 2016 – 2026 (USD Million)
      • 10.6.3 The Middle-East and Africa Preclinical CRO Treatment Market Revenue, By Type, 2016 – 2026
      • 10.6.4 The Middle-East and Africa Preclinical CRO Treatment Market Revenue, By Therapeutic Area, 2016 – 2026
      • 10.6.5 The Middle-East and Africa Preclinical CRO Treatment Market Revenue, By End-User, 2016 – 2026
      • 10.6.6 GCC Countries
      • 10.6.7 Rest of Middle-East Africa
  • Chapter 11 Company Profiles
    • 11.1 Paraxel International Corporation
      • 11.1.1 Company Overview
      • 11.1.2 Financial Overview
      • 11.1.3 Product Portfolio
      • 11.1.4 Business Strategy
      • 11.1.5 Recent Developments
    • 11.2 Laboratory Corporation of America
    • 11.3 Charles River Laboratories International, Inc.
    • 11.4 Eurofins Scientific
    • 11.5 Envigo
    • 11.6 Wuxi AppTec
    • 11.7 PRA Health Science, Inc.
    • 11.8 Pharmaceutical Product Development, LLC.
    • 11.9 Medpace, Inc.

List of Figures 

FIG. 1 Research Methodology
FIG. 2 Research Methodology – Basic Overview
FIG. 3 Research Methodology – Detailed View
FIG. 4 Global Preclinical CRO Treatment Market Revenue, 2016 - 2026 (USD Million)
FIG. 5 Porter’s Five Forces Analysis for Global Preclinical CRO Treatment Market
FIG. 6 Global Preclinical CRO Treatment Market Attractiveness, By Type
FIG. 7 Global Preclinical CRO Treatment Market Attractiveness, By Therapeutic Area
FIG. 8 Global Preclinical CRO Treatment Market Attractiveness, By End-User
FIG. 9 Global Preclinical CRO Treatment Market Attractiveness, By End-User
FIG. 10 Company Share Analysis, 2019
FIG. 11 Global Preclinical CRO Treatment Market Revenue Share, By Type, 2019 & 2026
FIG. 12 Global Preclinical CRO Treatment Market for Pharmacokinetics/Pharmacodynamics, Revenue (USD Million) 2016 - 2026
FIG. 13 Global Preclinical CRO Treatment Market for Early Phase Development Services, Revenue (USD Million) 2016 - 2026
FIG. 14 Global Preclinical CRO Treatment Market for Toxicology Testing, Revenue (USD Million) 2016 - 2026
FIG. 15 Global Preclinical CRO Treatment Market for Laboratory Services, Revenue (USD Million) 2016 - 2026
FIG. 16 Global Preclinical CRO Treatment Market for Clinic Research Services, Revenue (USD Million) 2016 - 2026
FIG. 17 Global Preclinical CRO Treatment Market for Stability Testing, Revenue (USD Million) 2016 - 2026
FIG. 18 Global Preclinical CRO Treatment Market for Physical Characterization, Revenue (USD Million) 2016 - 2026
FIG. 19 Global Preclinical CRO Treatment Market for Raw Material Testing, Revenue (USD Million) 2016 - 2026
FIG. 20 Global Preclinical CRO Treatment Market for Batch Release Testing, Revenue (USD Million) 2016 - 2026
FIG. 21 Global Preclinical CRO Treatment Market for Other Services, Revenue (USD Million) 2016 - 2026
FIG. 22 Global Preclinical CRO Treatment Market Revenue Share, By Therapeutic Area, 2019 & 2026
FIG. 23 Global Preclinical CRO Treatment Market for CNS Disorders, Revenue (USD Million) 2016 - 2026
FIG. 24 Global Preclinical CRO Treatment Market for Oncology, Revenue (USD Million) 2016 - 2026
FIG. 25 Global Preclinical CRO Treatment Market for Cardiovascular Diseases, Revenue (USD Million) 2016 - 2026
FIG. 26 Global Preclinical CRO Treatment Market for Infectious Diseases, Revenue (USD Million) 2016 - 2026
FIG. 27 Global Preclinical CRO Treatment Market for Respiratory Diseases, Revenue (USD Million) 2016 - 2026
FIG. 28 Global Preclinical CRO Treatment Market for Immunological Diseases, Revenue (USD Million) 2016 - 2026
FIG. 29 Global Preclinical CRO Treatment Market for Diabetes, Revenue (USD Million) 2016 - 2026
FIG. 30 Global Preclinical CRO Treatment Market for Others, Revenue (USD Million) 2016 - 2026
FIG. 31 Global Preclinical CRO Treatment Market Revenue Share, By End-User, 2019 & 2026
FIG. 32 Global Preclinical CRO Treatment Market for Medical Device Companies, Revenue (USD Million) 2016 - 2026
FIG. 33 Global Preclinical CRO Treatment Market for Pharmaceutical & Biopharmaceutical Companies, Revenue (USD Million) 2016 - 2026
FIG. 34 Global Preclinical CRO Treatment Market for Academic Institutes, Revenue (USD Million) 2016 - 2026
FIG. 35 Global Preclinical CRO Treatment Market Revenue Share, by Region, 2019 & 2026
FIG. 36 North America Preclinical CRO Treatment Market Revenue, 2016 - 2026 (USD Million)
FIG. 37 Europe Preclinical CRO Treatment Market Revenue, 2016 - 2026 (USD Million)
FIG. 38 Asia Pacific Preclinical CRO Treatment Market Revenue, 2016 - 2026 (USD Million)
FIG. 39 Latin America Preclinical CRO Treatment Market Revenue, 2016 - 2026 (USD Million)
FIG. 40 The Middle-East and Africa Preclinical CRO Treatment Market Revenue, 2016 - 2026 (USD Million)
FIG. 41 Paraxel International Corporation Business Segment Revenue Share, 2018 (%)
FIG. 42 Paraxel International Corporation Geographical Segment Revenue Share, 2018 (%)
 


List of Tables

TABLE 1 Global Preclinical CRO Treatment Market: Snapshot
TABLE 2 Drivers of the Preclinical CRO Treatment Market: Impact Analysis
TABLE 3 Restraints for the Preclinical CRO Treatment Market: Impact Analysis
TABLE 4 Global Preclinical CRO Treatment Market Revenue, by Region, 2016 – 2026 (USD Million)
TABLE 5 North America Preclinical CRO Treatment Market Revenue, by Country, 2016 – 2026 (USD Million)
TABLE 6 North America Preclinical CRO Treatment Market Revenue, By Type, 2016 – 2026 (USD Million)
TABLE 7 North America Preclinical CRO Treatment Market Revenue, By Therapeutic Area, 2016 – 2026 (USD Million)
TABLE 8 North America Preclinical CRO Treatment Market Revenue, By End-User, 2016 – 2026 (USD Million)
TABLE 9 Europe Preclinical CRO Treatment Market Revenue, by Country, 2016 – 2026 (USD Million)
TABLE 10 Europe Preclinical CRO Treatment Market Revenue, By Type, 2016 – 2026 (USD Million)
TABLE 11 Europe Preclinical CRO Treatment Market Revenue, By Therapeutic Area, 2016 – 2026 (USD Million)
TABLE 12 Europe Preclinical CRO Treatment Market Revenue, By End-User, 2016 – 2026 (USD Million)
TABLE 13 Asia Pacific Preclinical CRO Treatment Market Revenue, by Country, 2016 – 2026 (USD Million)
TABLE 14 Asia Pacific Preclinical CRO Treatment Market Revenue, By Type, 2016 – 2026 (USD Million)
TABLE 15 Asia Pacific Preclinical CRO Treatment Market Revenue, By Therapeutic Area, 2016 – 2026 (USD Million)
TABLE 16 Asia Pacific Preclinical CRO Treatment Market Revenue, By End-User, 2016 – 2026 (USD Million)
TABLE 17 Latin America Preclinical CRO Treatment Market Revenue, by Country, 2016 – 2026 (USD Million)
TABLE 18 Latin America Preclinical CRO Treatment Market Revenue, By Type, 2016 – 2026 (USD Million)
TABLE 19 Latin America Preclinical CRO Treatment Market Revenue, By Therapeutic Area, 2016 – 2026 (USD Million)
TABLE 20 Latin America Preclinical CRO Treatment Market Revenue, By End-User, 2016 – 2026 (USD Million)
TABLE 21 The Middle-East and Africa Preclinical CRO Treatment Market Revenue, by Country, 2016 – 2026 (USD Million)
TABLE 22 The Middle-East and Africa Preclinical CRO Treatment Market Revenue, By Type, 2016 – 2026 (USD Million)
TABLE 23 The Middle-East and Africa Preclinical CRO Treatment Market Revenue, By Therapeutic Area, 2016 – 2026 (USD Million)
TABLE 24 The Middle-East and Africa Preclinical CRO Treatment Market Revenue, By End-User, 2016 – 2026 (USD Million)

Methodology

Choose License Type

Request the coronavirus impact analysis across industries and markets

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (844) 845-5245
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #

US OFFICE NO +1 (844) 845-5245
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed